News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

June 22, 2023
June 22, 2023
Categories

The ECOG-ACRIN Clinical Research Associates (CRA) Core Committee is seeking candidates

Do you like it?
Read more
June 16, 2023
June 16, 2023
Categories

Media Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials

Do you like it?
Read more
June 1, 2023
June 1, 2023
Categories

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

Do you like it?
Read more
May 31, 2023
May 31, 2023
Categories

NCI-MATCH named among five innovative oncology therapies changing the game

Do you like it?
Read more
May 31, 2023
May 31, 2023
Categories

Your daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG

Do you like it?
Read more
May 30, 2023
May 30, 2023
Categories

Group leaders talk with The Cancer Letter about the cisplatin chemotherapy shortage (login required)

Do you like it?
Read more
May 17, 2023
May 17, 2023
Categories

Press Release: ECOG-ACRIN announces the recipients of its 2023 scientific leadership and mentorship awards

Do you like it?
Read more
May 11, 2023
May 11, 2023
Categories

Press Release: Historic achievement for the ongoing InPACT penile cancer trial—100 patients enrolled thus far, the most ever to a prospective study in this extremely rare disease

Do you like it?
Read more
April 29, 2023
April 29, 2023
Categories

A TAILORx post hoc analysis is the first to show racial and ethnic differences in locoregional breast cancer recurrence

Do you like it?
Read more
April 28, 2023
April 28, 2023
Categories

JAMA Surgery publishes TAILORx analysis showing that racial and ethnic differences in locoregional breast cancer recurrence patterns are prevalent even in a clinical trial population with similar access to care

Do you like it?
Read more
April 26, 2023
April 26, 2023
Categories

Two new studies shed light on cancer detection in dense breasts as researchers emphasize the need for the TMIST trial

Do you like it?
Read more
April 26, 2023
April 26, 2023
Categories

An AI algorithm may help better guide oropharynx cancer treatment

Do you like it?
Read more
April 21, 2023
April 21, 2023
Categories

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

Do you like it?
Read more
April 19, 2023
April 19, 2023
Categories

The March/April 2023 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
April 7, 2023
April 7, 2023
Categories

American College of Radiology (ACR) leader highlights TMIST mammography trial in testimony supporting NIH funding increase

Do you like it?
Read more
April 6, 2023
April 6, 2023
Categories

E1411 study chair Mitchell Smith discusses the use of ibrutinib for patients with previously treated mantle cell lymphoma

Do you like it?
Read more
March 23, 2023
March 23, 2023
Categories

The Spring 2023 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
March 21, 2023
March 21, 2023
Categories

In this video interview, Dr. Neha Vapiwala discusses the INDICATE (EA8191) trial and changing the trajectory of prostate cancer through radiation and imaging techniques

Do you like it?
Read more
March 8, 2023
March 8, 2023
Categories

The ComboMATCH patient registration trial and three treatment trials are now open

Do you like it?
Read more
February 27, 2023
February 27, 2023
Categories

The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

Do you like it?
Read more
Load more
News and Info

About Us Home Page

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Bladder cancer Breast cancer Cancer screening Cancer treatment Care delivery Clinical trial ComboMATCH Disparities Diversity Gastric cancer Gene testing Genomic testing GI cancer Group meeting Head and neck cancer Health equity Hogkin lymphoma Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma NCI-MATCH Non-Hodgkin lymphoma Pancreatic cancer Personalized screening Personalized treatment Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Skin cancer Social determinants of health (SDoH) Survivorship TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group